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Abstract 
Retinal degeneration (RD) in the Miniature Long Haired Dachshund (MLHD) is a cone-rod dystrophy 
resulting in eventual blindness in affected individuals. In a previous study a 44-nucleotide insertion 
(ins44) in exon 2 of RPGRIP1 was associated with RD. However, results on an extended population 
of MLHD revealed a variable RD onset age for ins44 homozygous dogs. Further investigations using 
a genome-wide association study comparing early onset and late onset RD cases, identified an age of 
onset modifying locus for RD, approximately 30Mb upstream of RPGRIP1 on chr15. In this 
investigation target enriched sequencing identified a MAP9 deletion spanning approximately 22 kb 
associated with early RD onset. Identification of the deletion required correction to the CanFam3.1 
genome build as canine MAP9 is part of a historic tandem duplication, resulting in incomplete 
assembly of this genome region. The deletion breakpoints were identified in MAP9 intron 10 and in a 
downstream partial MAP9 pseudogene. The fusion of these two genes, which we have called 
MAP9EORD (Microtubule associated protein, early onset retinal degeneration), is in frame and is 
expressed at the RNA level, with the 3’ region containing several predicted deleterious variants. We 
speculate that MAP9 associates with α-tubulin in the basal body of the cilium. RPGRIP1 is also 
known to locate to the cilium, where it is closely associated with RPGR. RPGRIP1 mutations also 
cause redistribution of α-tubulin away from the ciliary region in photoreceptors. Hence a MAP9 
partial deficit is a particularly attractive candidate to synergise with a partial RPGRIP1 deficit to cause 
a more serious disease.    
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Introduction  
Retinal degeneration (RD) in the Miniature Long Haired Dachshund (MLHD), first described by 
Barnett et al (Curtis and Barnett 1993) and later further clinically characterised by Turney et al 
(Turney et al. 2007), is a cone-rod dystrophy where first the cone and then the rod photoreceptors of 
the retina become depleted resulting in eventual blindness. The disease was first characterised in a 
colony of MLHD segregating RD in a manner consistent with an autosomal recessive inheritance. 
Clinical signs included tapetal hyperreflectivity, early cone-specific ERG amplitude reduction, and, to 
a lesser extent, a reduction in rod ERG amplitude. Degeneration progressed fully with no detectable 
ERG responses after 40 weeks of age in RD affected colony dogs (Turney et al. 2007). 
Genetic analysis of the RD which segregated within a closed breeding colony of MLHD identified a 
44-nucleotide insertion (ins44) in exon 2 of the retinitis pigmentosa GTPase regulator-interacting 
protein 1 (RPGRIP1) gene (Mellersh et al. 2006). This variant was predicted to alter the reading 
frame, causing a frameshift and premature termination. The variant segregated perfectly within the 
breeding colony and given the strong association of RPGRIP1 with Leber congenital amaurosis in 
human populations (Dryja et al. 2001; Gerber et al. 2001) and predictions for a truncated protein, the 
insertion was deemed likely to be the cause of RD for this particular dog breed. 
Despite perfect concordance of ins44 with RD in the closed breeding colony, evidence from DNA 
testing laboratories, breeders and veterinarians indicated that there was considerable phenotype-
genotype discordance within MLHDs that were not directly related to the experimental colony as not 
all dogs that were homozygous for ins44 were developing early onset RD (EORD), but in fact were 
developing RD at a much later stage or not at all within their lifespan. A study of 59 sporadic cases 
and 200 apparently normal controls from the MLHD pet dog population revealed 16 % of controls to 
be homozygous for ins44 and 20% of cases as non-homozygous for ins44 (Miyadera et al. 2009). In 
an independent study of 23 control MLHD and 34 ins44 homozygotes, it was demonstrated that the  
ins44 homozygous genotype does not invariably lead to the early cone-rod retinal dystrophy (cord) 
phenotype (Busse et al. 2011). Age of RD onset ranges of from 0.3 to 15 years among ins44 
homozygous dogs in the wider population and subsequently an age of onset modifying locus was 
identified for RD in the MLHD using a genome-wide association study approach comparing EORD 
with late onset RD (LORD) cases, although the modifying variant was not identified (Miyadera et al. 
2012b). 
The ins44 mutation has also been identified in the English Springer Spaniel (ESS) and heterozygously 
in the Labrador Retriever and French bulldog dog breeds. In addition a slightly longer insert (ins69) 
was detected at the same position in Beagles (BE), including homozygous individuals (Miyadera et al. 
2009). A small study investigating RD in ESS from the US showed that out of six ins44 homozygous 
ESS dogs, four showed clinical signs, suggesting that an age of onset modifying locus may also play a 
role in development of RPGRIP1 associated disease in the ESS (Narfstrom et al. 2012). In the same 
study investigation of Swedish ESS showed eight out of ten cases of RD in the ESS were not 
homozygous for the ins44 variant suggesting potential alternative clinical or genetic causes of RD in 
this breed. 
Since the identification of the RPGRIP1 ins44 mutation, experimental data from retinal RNA studies 
of ins44 dogs has shown that rather than causing an insertion of an aberrant string of codons and a 
frameshift, the ins44 mutation actually results in an alternative splicing pattern and skipping of exon 2 
of RPGRIP1. But despite exon 2 skipping in cRPGRIP1Ins44/Ins44 dogs, the protein pattern detected 
in western blots with an antiRPGRIP1 antibody is the same as in cRPGRIP1+/+ and 
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cRPGRIP1+/Ins44 retinal samples. (Kuznetsova et al. 2012). This study proposed exclusion of ins44 
as the causal variant for RD and suggested an alternative (as yet unidentified) variant either within 
RPGRIP1 or within the mapped region as the true cause of RD. 
As RPGRIP1 is associated with human Leber congenital amaurosis, RPGRIP1 associated RD in the 
dog has been considered as a potential model for gene therapy studies since the identification of the 
ins44 variant (Lheriteau et al. 2009). In a recent study using ins44 homozygous dogs derived from the 
original colony presenting early onset RD cases, gene therapy was reported to have been successfully 
used to significantly and stably rescue cone function, by subretinal injection of adeno-associated virus 
(AAV) encoding canine RPGRIP1 (Lheriteau et al. 2014). These experiments either provide evidence 
that a mutation in RPGRIP1 or a mutation affecting its expression is causal of RD in the dog, or that 
overexpression of RPGRIP1 is capable of re-establishing a normal phenotype. 
Since its identification, the ins44 insertion has been subject to scientific investigation, discussion and 
debate. However, regardless of whether the ins44 mutation is the causal mutation for RD in the 
MLHD, or whether the causal mutation is an alternative variant in close linkage disequilibrium with 
the ins44 variant, there is clear evidence that the age of onset of RPGRIP1-associated RD in this breed 
is influenced by a modifying locus, approximately 30Mb away on chr15 (Miyadera et al. 2012b)  The 
purpose of this study was to identify the age modifying variant, with the aim of improving the 
understanding of RPGRIP1 associated RD.  
Materials and methods 
DNA was extracted from whole blood using the Nucleon BACC2 DNA extraction kit (GE 
Healthcare). DNA was extracted from buccal swabs using the QIAamp Midi kit (Qiagen). 
Probes for target enrichment were designed using the design tool eArray with libraries prepared and 
sequenced at The Genome Analysis Centre, Norwich. The library for genome sequencing was 
prepared using the NEBNext Ultra DNA Library Prep Kit for Illumina, and sequencing performed on 
the Illumina MiSeq platform, generating an 82.5Gb dataset of 300 bp paired-end reads. Alignment of 
reads to the reference genome CanFam3.1 was performed using BWA (Li and Durbin 2009) and 
variants were called using GATK (McKenna et al. 2010).  
Screening of 23,040 clones of a canine BAC library (RPCI-81: Male Doberman Pinscher) was 
performed by qPCR of diluted cell lysates of glycerol stocks. Quantitative PCRs were carried out 
using KAPA Probe Fast qPCR ready mix on an ABI stepone plus real-time PCR machine. Positive 
BAC clones were streaked from glycerol stocks onto LB agar containing 12.5 mg/ml 
chloramphenicol, and picked colonies grown in liquid LB containing 12.5 mg/ml chloramphenicol. 
BAC DNA was isolated using the ZR BAC DNA Miniprep Kit. Long PCRs were performed using 
KAPA HIFI Hot Start Ready Mix. Libraries for sequencing of BAC DNA and long PCR products on 
the Illumina MiSeq platform were prepared using the NEBNext Ultra DNA Library Prep Kit for 
Illumina. De novo assembly was performed using SOAPdenovo (Xie et al. 2014). 
RNA was extracted from spleen using the Qiagen RNeasy Midi Kit. Reverse transcription was 
performed using the Qiagen Quantitect reverse transcription kit. Expression analysis of MAP9 
transcripts was performed using KAPA Probe Fast qPCR ready mix on an Illumina Eco qPCR 
machine. All primers are listed in Supplementary File 1. 
Results  
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Target enriched massively-parallel sequencing was used to generate sequence data for two EORD 
cases and eight controls (LORD cases), all of which were homozygous for the RPGRIP1 ins44 
variant. The genomic target was the mapped interval for the age of onset modifying locus 
(chr15:51,980,056-53,979,789 CanFam3.1), with 82 % of the target region covered by at least two 
reads and 73 % of the target region achieved at least 20x coverage. 
Sequence read alignments to the canine genome build CanFam3.1 identified 11,494 SNP and indel 
variants. Simple variants were filtered by how closely they segregated with disease status and 
consequence predictions. After filtering only one plausible variant remained – a SNP causing an 
amino acid substitution (S107Y) in the gene encoding cathepsin O (CTSO), which was predicted to be 
damaging through computational analysis using SIFT (Ng and Henikoff 2003). By coincidence, this 
variant is included on the Illumina CanineSNP20 bead chip and had thus been genotyped in the cohort 
of MLHDs investigated by the genome-wide association study to map the modifying locus (ID: 
BICF2S2353161). Despite being the single SNP with the lowest associated p-value (top SNP), the 
presence of several late onset individuals that were homozygous for the disease-associated CTSO 
variant meant that this variant could be excluded. 
Further investigation of the modifying locus was carried out by visualising read alignments exon by 
exon and considering differences between EORD cases and controls (LORD cases). A region of zero 
read depth in EORD cases, but substantial read depth in controls was identified across exon 9 of the 
gene encoding microtubule associated protein 9 (MAP9) (Figure 1). The presence of a large number 
of reads aligning with a mapping quality of zero, which indicate more than one possible genomic 
coordinate for an alignment, suggested that the region was repetitive in nature. In addition no reads 
were identified that spanned the region of zero read depth for early onset cases, which would usually 
indicate a deletion. The reads with a mapping quality of zero also aligned perfectly to 
chrUn_AAEX03022082, a 21 kb scaffold with no designated chromosome. A gene with high 
sequence similarity to MAP9 exon 8 through to exon 14, including introns, was present on 
chrUn_AAEX03022082. Short PCR across the region of zero read depth yielded products with no 
size difference between EORD and LORD cases due to the level of sequence similarity between the 
MAP9 region on chr15 and the MAP9-like region on chrUn_AAEX03022082. Although no capture 
probes were specifically designed to capture chrUn_AAEX03022082, the region was inadvertently 
captured due to the high levels of sequence similarity. In addition to the zero read depth shown for 
exon 9 of MAP9 on chr15 for EORD cases, no read alignments were seen for exons 11 through to 14 
of the MAP9-like gene on chrUn_AAEX03022082. We sought to assemble chrUn_AAEX03022082 
into the genome sequence to help determine the exact nature of the sequence variant identified. 
In an attempt to determine the exact genomic assembly point for chrUn_AAEX03022082, screening 
of a canine BAC library (RPCI-81: Male Doberman Pinscher) was carried out to isolate clones 
containing chrUn_AAEX03022082. Two clones were identified, 36I10 and 40O5, for which BAC 
DNA was sequenced using a massively parallel approach. BAC ends were identified at coordinates 
chr15:52,766,756 and chr15:52,920,909 for isolate 40O5 indicating an assembly point within the 
chr15 MAP9 region. Sequencing data alignments for BAC isolate 36I10 identified BAC ends at 
chr15:52,778,639 and chrUn_AAEX03022082:3,729, identifying the chromosome 15 assembly point. 
De novo assembly of the BAC sequencing data was used to bridge the 5’ assembly point between 
chr15 and ChrUn_AAEX03022082.  
Although the 5’ assembly position had been determined through BAC sequencing further PCR based 
investigation was required to determine the 3’ assembly point. Alignment of chrUn_AAEX03022082 
to chr15 using BLAST identified two regions only present on chromosome 15 that had no similarity 
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to chrUn_AAEX03022082, allowing specific long PCR spanning from chr15 into 
chrUn_AAEX03022082 across the 3’ assembly point (Figure 2). Sequencing and de novo assembly of 
the long PCR product enabled the new assembly of chromosome 15 containing 
chrUn_AAEX03022082 to be completed. The assembly point for chrUn_AAEX03022082 was 
chr15:52,909,237 with a new end point of 52,930,899. Bases 1-74 of chrUn_AAEX03022082 (part of 
MAP9 exon 8) were corrected as part of the assembly process. A novel 280 bp sequence was added 
after chrUn_AAEX03022082 (chr15:52,930,899-52,931,179). We have given the new genome 
assembly the nominal title of CanFam3.1MAP9_corrected. 
The new assembly shows that the MAP9-like exons, which were previously part of 
chrUn_AAEX03022082, actually form the 3’ region of the MAP9 gene. The 3’ region of MAP9 on 
the previous assembly (exons 8 to 14) is the result of a partial duplication of the MAP9 gene and is a 
MAP9 pseudogene. Review of the BLAST results suggest exon 6 and 7 were part of the duplicated 
region, but have subsequently been deleted.  
Alignment of genome data generated for an EORD case and target enrichment data from EORD cases 
and controls to the newly assembled CanFam3.1MAP9_corrected, were suggestive of a deletion in EORD 
cases potentially through homologous recombination. The deletion was confirmed in EORD cases and 
not LORD cases by long PCR to produce a product spanning the deletion joins. A PCR specific to the 
deleted region yielded products only for LORD cases (Figure 3). Definition of the deletion 
breakpoints could only be defined to be within a 1666 bp region through visualising alignments of 
targeted enrichment and genome data due to low read mapping quality and spurious alignments 
(Supplementary File 2). Although precis  and certain definition of the deletion breakpoint was 
impossible due to the level of sequence similarity between the two genes, a minimal deletion 
join/breakpoint region of 231 bp was identified using multiple sequence alignment of de novo 
assembled reads generated from the PCR product spanning the deletion (Supplementary File 3). The 
5’ region of the join showed sequence similarity to the region upstream of the 5’ deletion breakpoint 
and the 3’ region of the join showed sequence similarity to region downstream of the 3’ deletion 
breakpoint. The size of deletion based on new genome build CanFam3.1MAP9_corrected is 21,961 bp, with 
deletion breakpoints in intron 10 of MAP9 and MAP9 pseudogene(chr15:52,905,335-52,905,565 and 
chr15:52,927,296-52,927,527 (chrUn_AAEX03022082:3,379-3,609)). The new genome arrangement 
with key coordinates are shown graphically in Figure 4 and a timeline of chromosome 15 
rearrangement events summarised in Figure 5. 
Despite the deletion, the joining of MAP9 with the MAP9like pseudogene appears to produce a 
complete MAP9 reading frame which we have termed MAP9EORD.  Sequencing of cDNA from spleen 
of an EORD case (used as retina tissue was unavailable) confirmed that a full length product and in 
frame transcript was produced from the MAP9EORD gene. A number of residue changes were identified 
between the canine MAP9EORD and canine MAP9 transcripts. Multiple sequence alignment was 
performed alongside human MAP9, and vertebrate species conservation was considered for variant 
residues (Supplementary file 4). The PolyPhen tool was used to predict whether the variants could 
alter protein function. The variant N555K was private to EORD cases on consideration of vertebrate 
species alignments, and was predicted by PolyPhen to be probably deleterious. The variant N579S 
was also predicted by PolyPhen to be probably deleterious and is a highly conserved residue across 
species. The deleted residue E584 is also highly conserved amongst vertebrate species. 
Association of MAP9EORD with the EORD phenotype was investigated by genotyping a subset of the 
EORD and LORD cases used for mapping of the early onset locus. The arbitrary age boundary for 
EORD cases was set at 5 years of age, and LORD cases were defined as diagnosed with RD at >5 
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years of age. In total there were 32 EORD cases and 18 LORD cases. Of the 30 EORD cases that 
genotyped successfully 26 were homozygous for MAP9EORD and for the LORD cases, one was 
homozygous for MAP9EORD (Table 1). The LORD case, which was homozygous for MAP9EORD had an 
age of diagnosis of 5.2 years of age i.e. close to the arbitrary cutoff, and quite likely to have had an 
onset age below 5y. In addition the sample set was genotyped for the top SNP from the age of onset 
locus genome-wide association study. Allelic association analysis performed on the top SNP and the 
MAP9EORD genotypes gave p-values of 1.4 x 10
-5and 4.0 x 10-8 respectively. A full description of 
results is show in Supplementary File 5. 
The gene duplication, which is present in the canine reference sequence (Boxer) and the MLHD, was 
investigated in 96 dogs of 32 other breeds , by specific qPCR across the duplication join (i.e. within 
the MAP9 deletion region). Three dogs of each of the following breeds were investigated: American 
Cocker Spaniel, Australian Shepherd, Boxer, Border Collie, Brittany Spaniel, Chesapeake Bay 
retriever, Cocker Spaniel, Doberman, English Springer Spaniel, Flat Coated Retriever, Field Spaniel, 
Grand Basset Griffon Vendeen, Great Dane, Golden Retriever, Giant Schnauzer, Hovawarts, Irish 
setter, Italian Spinone, Lancashire Heeler, Labrador Retriever, Miniature Bull Terrier, Miniature 
Poodle, Otterhound, Staffordshire Bull Terrier, Scottish Deerhounds, Soft-coated Wheaten Terrier, 
Standard Poodle, Shetland Sheepdogs, Tibetan Spaniel, Tibetan Terrier, West Highland White 
Terrier, and Welsh Springer Spaniel. Deletion alleles were identified in two individuals of two breeds, 
the Tibetan Terrier and Brittany. These alleles were further investigated using long PCR followed by 
massively parallel sequencing. Read alignment patterns and SNP analysis suggested a novel deletion 
event had occurred in the Tibetan Spaniel. The Brittany deletion showed high similarity to the 
deletion identified for the MLHD (Supplementary File 6). Genome comparison by BLAST suggests 
that the duplication is not present in the cat, the phylogenetically most similar genome sequence to the 
dog available.  
To determine the frequency of the MAP9EORD allele within the Miniature Dachshund (MD) and ESS 
populations, 640 MDs (202 long haired, 348 smooth haired and 90 wire haired) and 206 ESSs were 
genotyped. Two MLHDs were homozygous for MAP9EORD (one ins44 homozygote and one ins44 
heterozygote). A carrier frequency of 17.92% for the MLHD population was calculated assuming 
Hardy Weinberg equilibrium (q= 0.0995). No MAP9EORD homozygotes were identified in the ESSs 
sample set.  
Discussion 
Cone-rod RD in the MLHD is an example of a canine disease that segregates as a seemingly early 
onset recessive trait in an inbred population but manifests differently within a wider population albeit 
of the same breed. In this investigation we built on a previous age of onset locus mapping study, by 
using target enrichment data to identify a genomic deletion across MAP9 as the potential age of onset 
modifying mutation.   
The primary defect in the cone rod degeneration in a colony of MLHDs is known to be in RPGRIP1, 
caused by either or both of a polyA tract insertion in exon 2 of the gene (Mellersh et al. 2006) and a 
mutation elsewhere in the same confidence interval (Kuznetsova et al. 2012). The RPGRIP1 mutation 
is leaky (Miyadera et al. 2012a; Miyadera et al. 2009) and gives rise to LORD or no clinically 
significant phenotype in the absence of a second homozygous mutation segregating in the interval 
containing MAP9 (Miyadera et al. 2012b). Here we have shown that RPGRIP1 ins44/ins44 dogs with 
EORD have several polymorphisms in MAP9, some of them potentially harmful, when compared with 
MAP9 in LORD dogs. We hypothesise that this reflects a partial deficit in MAP9 protein function in 
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the retina. This finding adds to a growing number of examples of modifiers affecting the RD 
phenotype mostly in mice models as well as in humans (Khanna et al. 2009; Maddox et al. 2012; 
Markand et al. 2015; Schon et al. 2016; Venturini et al. 2012; Vollrath et al. 2015). 
MAP9, also known as ASAP (aster-associated protein), is associated with microtubules in interphase, 
with the mitotic spindle at mitosis, and with the centrosome during cytokinesis. It binds directly to 
pre-polymerised α-tubulin microtubules in vitro through its C-terminal domain, and co-sediments 
with cellular microtubules ex-vivo (Saffin et al. 2005). Phosphorylation of MAP9 at serine 625 
(human, 626 in dog) by Aurora A kinase is essential for correct assembly onto centrosomes and for 
mitotic progression (Venoux et al. 2008). This residue is preserved in both the MAP9 proteins 
described here. MAP9 is probably expressed in all cell types, but shows high level expression in 
testes, brain, eye, spinal cord, fertilised ovum, and intermediate expression in kidney, heart, lung and 
a small number of other tissues. Within the eye, expression is known to be high in the retina, at least 
in the zebrafish (Saffin et al. 2005). Expression has not been mapped at this level in other species. In 
non-dividing cells such as photoreceptors the centrosome contributes a centriole to form the basal 
body of the primary cilium. Although not proven, it is likely that MAP9 remains associated with the 
α−tubulin in the basal body and MAP9 has been associated with the cytoskeletal component of the 
murine photoreceptor cilium (Liu et al. 2007), whilst in zebra fish, eye development is especially 
sensitive to morpholino driven reduction in MAP9 availability (Fontenille et al. 2014).  RPGRIP1 is 
also known to locate to the ciliary axoneme, where it is closely associated with RPGR, and appears to 
act as a ciliary targeting protein for RPGR, NPHP4 and SDCCAG8 (Bolan and Wright, 2000; Hong et 
al. 2001; Patil et al. 2012; Roepman et al. 2005; Shu et al., 2005; Zhao et al. 2003) mutations in each 
of which cause a different retinal degeneration in dogs or other species. These degenerations have all 
been commonly described as ciliopathies. RPGRIP1 mutations have profound effects on the stability 
and maintenance of the connecting cilium and its ability to support outer segment morphogenesis (e.g. 
Zhao et al., 2003). Changes in the cilium in  RPGRIP1
-
 animals include reductions in acetylated 
α−tubulin in the axoneme in photoreceptors (Patil et al. 2012). Hence a MAP9 partial deficit is a 
particularly attractive candidate to synergise with a partial RPGRIP1 deficit to cause a more serious 
disease. It is notable that MAP9 is highly expressed in spermatogonia and in spermatocytes (Saffin et 
al. 2005). It is tempting to speculate that the original colony of cord1 (EORD) MLHD, in which low 
fertility was a persistent problem (Debra Flack, personal communication) and the EORD haplotype at 
MAP9 was fixed, may have been showing a syndromic effect of the MAP9 mutation described here. 
On the other hand up to one third of all retinopathies are non-syndromic ciliary defects even though 
many of the mutated genes are expressed widely outside the eye (Estrada-Cuzcano et al. 2012). 
Identification of the MAP9 deletion was facilitated by correction of the canine genome build 
CanFam3.1. In the new assembly, which we have given the nominal title CanFam3.1MAP9_corrected, there 
is evidence of a historic partial duplication of MAP9 through a hypothesised homologous 
recombination event. The tandem repeat structure explains the difficulty in assembling this region for 
the CanFam3.1 genome build. A subsequence deletion event, which again is likely to have occurred 
through homologous recombination, gives rise to a fusion of two halves of the partially duplicated 
MAP9 gene to give a new gene, MAP9EORD, which is strongly associated with the EORD phenotype. 
Investigation of other breeds for this variant identified individuals of two breeds, the Tibetan Terrier 
and Brittany Spaniel, with a similar gene arrangement to MAPEORD. Haplotype analysis of these breeds 
showed that at least one of the deletion events appeared novel, further highlighting the region’s 
vulnerability to rearrangement (Supplementary File 6). From our available clinical data there appears 
to be no phenotype associated solely with MAP9EORD although formal investigation would be required 
to rule this possibility out.   
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Although the CanFam3.1 genome build is largely complete, there are still 15 unplaced scaffolds 
(unattached scaffolds, which are not assigned to a chromosomal location) and 223 unlocalised 
scaffolds, for which the chromosome is known, but the position and orientation is not. As many of 
these scaffolds are likely to contain very repetitive regions of the genome, it is likely that further 
improvement to the genome build will require the use of ultra-long read sequencing technology. 
Analysing short massively parallel sequence read alignments across repetitive regions is challenging. 
Although sequence reads may be accurate, a single variant in the reference sequence can result in 
reads aligning to an alternative region, leading to a gap in coverage and potentially falsely indicating a 
deletion. The opposite may also be also be true, where a deletion may be present but if reads map 
equally to both the deleted region and an alternative region, then the deleted region could be masked 
to some extent by reads of mapping quality zero. Both of these factors made detection of the deletion 
region and determination of the likely deletion breakpoints challenging.  
Diagnostic DNA testing, which is commonly used in the dog, for MAP9EORD is challenging as a short 
PCR based assay is difficult to develop due to the unavailability of specific priming sites and long 
range PCR techniques may lack sensitivity, especially for DNA samples extracted from buccal swabs. 
Detection of presence or absence of MAPEORD by qPCR can be used to specify early onset or late onset 
status for ins44 homozygotes however, and also enables MAPEORD allele frequency estimates. Our 
data suggests MAP9EORD frequency is low in the MD population, implying that the majority of 
RPGRIP1 ins44 dogs are not likely to have the EORD phenotype. No MAP9EORD alleles were detected 
in the ESS sample set. Although a larger sample set would be required to rule out the presence of 
MAP9EORD, the result suggests that early onset retinal degeneration in the ESS is due to an alternative 
modifier or a separate genetic or clinical cause. 
To summarise we have identified a deletion across the tandemly duplicated MAP9 gene in the canine 
genome which segregates closely with EORD in the MLHD. Although a full MAP9 open reading 
frame is maintained, the deletion results in the introduction of a number of variants which are 
predicted to be deleterious. This is a consequence of the 3’ region being formed from a redundant 
MAP9 partial pseudogene. We speculate that the interaction between MAP9 and RPGRIP1 are 
important in the function of the retina, and disruption of MAP9 in the context of RPGRIP1 ins44 
mutation homozygosity result in the EORD phenotype.  
Using different inbred populations of dog we have been able to tease apart the genetic basis of an 
inherited trait with a variable age of onset and demonstrate the interaction of two independent loci that 
contribute to the phenotype.  The variation in age of onset between populations is explained by the 
fact that one of the populations was fixed for the modifier locus so the trait effectively segregated as a 
simple Mendelian trait in that population, an important consideration for the study of recessive 
conditions with small sample sets from closed or restricted populations  
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Table 1: Genotype phenotype correlation for MAP9EORD 
MAP9EORD genotype wt/wt wt/del del/del 
EORD cases 1 1 21 
LORD cases 13 9 1 
  
Figure 1: Area of zero read depth in target enrichment sequence data for EORD cases. 
Alignment of target enrichment sequence read data against the CanFam3.1 reference sequence 
revealed a region of zero read depth for EORD cases, but not for controls (LORD cases). The 
presence of a large number of reads in the region with zero mapping quality, suggested a region(s) of 
very high sequence similarity existed elsewhere in the genome. No paired alignments with greater 
than expected insert size were present, usually indicative of a deletion. 
Figure 2: BLAST results of chrUn_AAEX03022082 to chromosome 15. 
Alignment of the chrUn_AAEX03022082 sequence (A) against chromosome 15 (B) using BLAST, 
revealed two regions which were specific to chromosome 15 (marked with asterisks). Corresponding 
alignment blocks are number from 1-12 and coloured from red through to blue respectively. An 
apparent sequence join was identified on chrUn_AAEX03022082 (marked with a green dashed line), 
suggestive of a structural rearrangement event. 
Figure 3: MAP9EORD genotyping PCR 
Genotyping of MAP9EORD was carried out by performing one long PCR across the deletion 
breakpoints and a specific PCR within the deleted region. PCR products were pooled before running 
on an agarose gel. Lanes 2-4 show a single band representing a PCR product crossing the deletion join 
(All EORD cases). Lanes 5-6 show a single band representing the PCR within the deleted region. 
Lane 7 is a heterozygous individual. 
Figure 4: New assembly arrangement of chromosome 15.  
The newly assembled chromosome 15 sequence contains the MAP9 gene and a partial MAP9 
pseudogene which we have termed MAP9-like. The arrangement is likely to have occurred through 
partial tandem duplication of MAP9 caused by homologous recombination. 
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Figure 5: Overview of events leading to MAP9EORD 
(A) Homologous recombination event leading to creation of a partial MAP9like pseudogene. This 
pseudogene is present in all 32 dog breeds investigated for this study, but may be private to the dog, 
although other closely related canid species have not been investigated. (B) Accumulation of variants 
in the non-conserved MAP9-like sequence. (C) Homologous recombination event leading to the 
creation of MAP9EORD. Although this gene is complete and expressed it possesses many variants 
compared to wildtype MAP9, that change conserved residues of the MAP9 protein. 
Supplementary File 1: Primer sequences 
Supplementary File 2: Sequence read alignments across the deletion breakpoint regions. 
Definition of the deletion breakpoints was not aided by alignment of targeted enrichment and genome 
data as poor mapping quality and spurious alignments meant the deletion breakpoint could only be 
defined to be within a 1666 bp region.  
Supplementary File 3: Multiple sequence alignments 
Multiple sequencing alignments of the de novo assembly of reads generated from the PCR product 
spanning the deletion to determine the most likely location of the deletion breakpoints.   
Supplementary File 4: Vertebrate sp cies conservation for MAP9EORD variant residues. 
Supplementary File 5: Top SNP and MAP9EORD genotyping results. 
Supplementary File 6: Alignment of massively parallel sequencing reads generated for a 
Tibetan Terrier and Brittany Spaniel with a deletion across MAP9 
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Figure 1: Area of zero read depth in target enrichment sequence data for EORD cases.  
Alignment of target enrichment sequence read data against the CanFam3.1 reference sequence revealed a 
region of zero read depth for EORD cases, but not for controls (LORD cases). The presence of a large 
number of reads in the region with zero mapping quality, suggested a region(s) of very high sequence 
similarity existed elsewhere in the genome. No paired alignments with greater than expected insert size 
were present, usually indicative of a deletion.  
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Figure 2: BLAST results of chrUn_AAEX03022082 to chromosome 15.  
Alignment of the chrUn_AAEX03022082 sequence (A) against chromosome 15 (B) using BLAST, revealed 
two regions which were specific to chromosome 15 (marked with asterisks). Corresponding alignment blocks 
are number from 1-12 and coloured from red through to blue respectively. An apparent sequence join was 
identified on chrUn_AAEX03022082 (marked with a green dashed line), suggestive of a structural 
rearrangement event.  
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Figure 3: MAP9EORD genotyping PCR  
Genotyping of MAP9EORD was carried out by performing one long PCR across the deletion breakpoints and a 
specific PCR within the deleted region. PCR products were pooled before running on an agarose gel. Lanes 2-
4 show a single band representing a PCR product crossing the deletion join (All EORD cases). Lanes 5-6 
show a single band representing the PCR within the deleted region. Lane 7 is a heterozygous individual.  
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Figure 4: New assembly arrangement of chromosome 15.  
The newly assembled chromosome 15 sequence contains the MAP9 gene and a partial MAP9 pseudogene 
which we have termed MAP9-like. The arrangement is likely to have occurred through partial tandem 
duplication of MAP9 caused by homologous recombination.  
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Figure 5: Overview of events leading to MAP9EORD  
(A) Homologous recombination event leading to creation of a partial MAP9like pseudogene. This pseudogene 
is present in all 32 dog breeds investigated for this study, but may be private to the dog, although other 
closely related canid species have not been investigated. (B) Accumulation of variants in the non-conserved 
MAP9-like sequence. (C) Homologous recombination event leading to the creation of MAP9EORD. Although 
this gene is complete and expressed it possesses many variants compared to wildtype MAP9, that change 
conserved residues of the MAP9 protein.  
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Supplementary File 1
MAP9 cDNA sequencing primers
cDNA_A_F ACCCGGTCAGAGTTTGAATC
cDNA_A_R AAGTGGTTGTTGGCTTCAGG
cDNA_B_F GCCCAGAATTCTTCCAGTCA
cDNA_B_R GAGGCACTGGACGCTCTATT
cDNA_C_case_F AATCGAGAAATCCCAGGAAAG
cDNA_C_case_R TCGGGCAGCTATTTTCTTTG
cDNA_D_case_F GCCTGGAAGGCTATGAAAGAA
cDNA_D_case_R CCCCAGATCATCTTCTCCATT
cDNA_C_control_F GCTGACACAACTGAGTCTTCAAA
cDNA_C_control_R AATTACATGCCGGCTGTTTC
cDNA_end_F AAATGGAATGAAAGGAAGGATG
cDNA_end_R TGTAGTACCCAGATGGCTTCC
cDNA_start_F CTCAGTCCCGGTCCGTCT
cDNA_start_R TGGTGACTTTCGGACTCTTTG
Primers for genotyping 
Deletion_region_F AAGTGAATAGCACTTGTGGCTC
Deletion_region_R TAATTCTGACCGTTTGAGGGTA 
Deletion_span_F TGGGAGCACTTCATTTAACCTCAA
Deletion_span_R GAAAGCAAATGAATCTGTTATCCACCT
Long PCR for sequencing and denovo assembly to bridge 3' assembly point
Assembly_3prime_F TGGAGTACCAGAAAGGAAATCAGAAA
Assembly_3prime_R GAAAGCAAATGAATCTGTTATCCACCT
BAC screening
BAC_probe /56-FAM/TACACCTCT/ZEN/CCTACTGCCTTACCTTC/3IABkFQ/
BAC_forward GATGTAGCCGTGACATCTGC
BAC_reverse GCCGGATAAGTCATTGAAGG
5' MAP9 qPCR
MAP9_5_probe /56-FAM/AGCTCATCC/Zen/TGGAAAGTAGTCCTTTTGG/3IABkFQ/
MAP9_5_forward TTTTAGCTTATACAAAGAGTCCGAAAG
MAP9_5_reverse TTCAGAACTCCTTTGCCTGG
3' MAP9 qPCR
MAP9_3_probe /56-FAM/TGAACGAAA/ZEN/ACAAAAGAAGCGTCA/3IABkFQ/
MAP9_3_forward AGGGAGGAAGTGCCTCATTT
MAP9_3_reverse TGAAAAATGGCTGGAAAAGAA
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5’ region 
into the 
deletion 
3’ region 
into the 
deletion 
5’ of the 
deletion 
3’ of the 
deletion 
potential deletion breakpoint region (1666bp) 
(complicated by poor mapping quality and misplaced alignments)  
Exon 10 Exon 11 
Exon 10 Exon 11 
MAP9pseudogene 
MAP9 
Supplementary File 2 
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Supplementary File 3 
 
 
CLUSTAL 2.1 multiple sequence alignment 
Positions are based on CanFam3.1 
 
N chrUn_AAEX03022082 specific variant 
N chr15 specific variant 
N polymorphic based on target enrichment data 
* Minimal deletion breakpoint region 
 
 
 
EORD                              CAGCTAGACACAAATGCAGGTGTGTGATATGGTGAAATGATGACTGCGGG 50 
chr15_52904890-52907293           CAGCTAGACACAAATGCAGGTGTGTGATATGGTGAAATGATGACTGCGGG 50 
chrUn_AAEX03022082_1656-4051      CAGCTAGACACAAATGCAGGTGTGTGATATGGTGAAATGATGACTGTGGG 50 
                                  ********************************************** *** 
 
EORD                              GACTCCAAGCCACTGAGTACCTGCAGCGCCTCTCCCTTTCTGGCAGCATT 100 
chr15_52904890-52907293           GACTCCAAGCCACTGAGTACCTGCAGCGCCTCTCCCTTTCTGGCAGCATT 100 
chrUn_AAEX03022082_1656-4051      GACTCCAAGCCACTGAGTACCTGAAGCGCCTCTCCCTTTCTGGCAGCATT 100 
                                  *********************** ************************** 
 
EORD                              TTCTTCCTCTGTTTTCTTCTTGTTTTTTTCCTCAAGCCTTTTTCGGGCAG 150 
chr15_52904890-52907293           TTCTTCCTCTGTTTTCTTCTTGTTTTTTTCCTCAAGCCTTTTTCGGGCAG 150 
chrUn_AAEX03022082_1656-4051      TTCTTCCTCTGTTTTCTTCTTGTTTTTTTCCTCAAGCCTTCTTTGGGCAG 150 
                                  **************************************** ** ****** 
 
EORD                              CTATTTTCTTTGCTTCCTTTTCTTTCATAGCCTTCCAGGCCTCAAAGGAT 200 
chr15_52904890-52907293           CTATTTTCTTTGCTTCCTTTTCTTTCATAGCCTTCCAGGCCTCAAAGGAT 200 
chrUn_AAEX03022082_1656-4051      CTATTTTCTTTGCTTCCTTTTCTTTCATAGCCTTCCAGGCCTCAAAGGAT 200 
                                  ************************************************** 
 
EORD                              GCTAATGCTTCTTCTCTCTTAGCAGCTCTTTTCTGTTTCAAAAAAATAAG 250 
chr15_52904890-52907293           GCTAATGCTTCTTCTCTCTTAGCAGCTCTTTTCTGTTTCAAAAAAATAAG 250 
chrUn_AAEX03022082_1656-4051      GCTAATGCTTCTTCTCTCTTAGCAGCTCTTTTCTGAT-CAAGAAAATAAG 249 
                                  *********************************** * *** ******** 
 
EORD                              AGACAGTGAGACGTGTGTGTATAAACAGACGGAGACAGGTAGATACGACA 300 
chr15_52904890-52907293           AGACAGTGAGACGTGTGTGTATAAACAGACGGAGACAGGTAGATACGACA 300 
chrUn_AAEX03022082_1656-4051      AGAC--TGAGACGTGTGTGCATAAACAGACGGAGACAGGTAGATACGACA 297 
                                  ****  ************* ****************************** 
 
EORD                              CACACATATGGATTGTGCTGAATTCCCTTCATAGTCATCATTTCGAGACA 350 
chr15_52904890-52907293           CACACATATGGATTGTGCTGAATTCCCTTCATAGTCATCATTTCGAGACA 350 
chrUn_AAEX03022082_1656-4051      CACACGTATGGATTGTGCTGAATTCCCTTCATAGTCATCATTTCGAGACA 347 
                                  ***** ******************************************** 
 
EORD                              TTGTTTTGCAGAGCAGGTGACTCATTTAGAATAGTTTAGACAAGCTGATT 400 
chr15_52904890-52907293           TTGTTTTGCAGAGCAGGTGACTCATTTAGAATAGTTTAGACAAGCTGATT 400 
chrUn_AAEX03022082_1656-4051      TTGTTTCGCAGAGCAGGTGACTTATTTAGAATAGCTTAGACAAGCTGATT 397 
                                  ****** *************** *********** *************** 
 
EORD                              TGGAAAAAAAATGTTACCGGAACTATTCATTGCATTTTAAATATCCTTTT 450 
chr15_52904890-52907293           TGGAAAAAAAATGTTACCGGAACTATTCATTGCATTTTAAATATCCTTTT 450 
chrUn_AAEX03022082_1656-4051      GGAAAAAAGAATGTCACCAGAACTATTCATTGCATTTAAAATATTCTTTT 447 
                                   * ***** ***** *** ****************** ****** ***** 
 
EORD                              CTAAAACCATTTATCAGATATTGATCTGCTATGAGAAAGACCTCTTTTTT 500 
chr15_52904890-52907293           CTAAAACCATTTATCAGATATTGATCTGCTATGAGAAAGACCTCTTTTTT 500 
chrUn_AAEX03022082_1656-4051      CTAAAACCATTTATCAGATATTGATCTGCTATGAGAAAGACCTCTTTTTT 497 
                                  ************************************************** 
 
EORD                              GGAAGCGTACTAAAATGTTATCTAAATAACCTATAAAGGCTGAGTGCTCC 550 
chr15_52904890-52907293           GGAAGCGTACTAAAATGTTATCTAAATAACCTATAAAGGCTGAGTGCTCC 550 
chrUn_AAEX03022082_1656-4051      GGAAGCGTACTAAAATGTTATCTAAATAAACTATAAAGGCTGAGTGCTCC 547 
                                  ***************************** ******************** 
 
EORD                              TGCAAAATGCTCATAATAAAACATTCCATCACAAGAAAAGGATCAGGAAA 600 
chr15_52904890-52907293           TGCAAAATGCTCATAATAAAACATTCCATCACAAGAAAAGGATCAGGAAA 600 
chrUn_AAEX03022082_1656-4051      TGCAAAATGCTCATAATAAAACATTCCATCACAAGAAAAGGATCAGGAAA 597 
                                  ************************************************** 
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EORD                              GTTACAGGTTTATAAAGTAAGTCAGAGTGGGGTAACCCGGCCAAGCCACT 650 
chr15_52904890-52907293           GTTACAGGTTTATAAAGTAAGTCAGAGTGGGGTAACCCGGCCAAGCCACT 650 
chrUn_AAEX03022082_1656-4051      GTTACAGGTTTATAAAGTAAGTCAGAGTGGGGTAACCCGGCCAAGCCACT 647 
                                  ************************************************** 
 
EORD                              TAGGAAGCCAAAATAGATCTTTGCTT-GAACCCGAGTTTTGGTGGACATT 699 
chr15_52904890-52907293           TAGGAAGCCAAAATAGATCTTTGCTTTGAACCCGAGTTTAGGTGGACATT 700 
chrUn_AAEX03022082_1656-4051      TAGGAAGCCAAAATAGATCTTTGCTT-GAACCCGAGTTTTGGTGGACATT 696 
                                  ************************** ************ ********** 
 
EORD                              AAACCATAAGATTGTGACAACACAAGCAGCACCCAAATATTGAACCTGTA 749 
chr15_52904890-52907293           AAACCATAAGATTGTGACAACACAAGCAGCACCCAAATATTGAACCTGTA 750 
chrUn_AAEX03022082_1656-4051      AAACCATAAGATTGTGACAACACAAGCAGCACCCAAATATTGAACCTGTA 746 
                                  ************************************************** 
 
EORD                              TGTTGGTGAGCATATGGTAGGTATGTTATTACTTGACTTACCTCCATCTA 799 
chr15_52904890-52907293           TGTTGGTGAGCATATGGTAGGTATGTTATTACTTGACTTACCTCCATCTA 800 
chrUn_AAEX03022082_1656-4051      TGTTGGTGAGCATACGGTAGGTATGTTATTACTTGACTTACCTCCATCTA 796 
                                  ************** *********************************** 
 
EORD                              ATCCCATACTATCCTTTGCCTAATAATTCTGTGTAATGTTACACGACATA 849 
chr15_52904890-52907293           ATCCCATACTATCCTTTGCCTAATAATTCTGTGTAATGTTACACGACATA 850 
chrUn_AAEX03022082_1656-4051      ATCCCATACTATCCTTTGCCTAATAATTCTGTGTAATGTTACACGACATA 846 
                                  ************************************************** 
 
EORD                              AAGCCTTACAAAGAGAAGACACTATTTAGGAGTAAAGGTACAAGCTACCT 899 
chr15_52904890-52907293           AAGCCTTACAAAGAGAAGACACTATTTAGGAGTAAAGGTACAAGCTACCT 900 
chrUn_AAEX03022082_1656-4051      AAGCCTTACAAAGAGAAGACACTATTTAGGAGTAAAGGTACAAGCTACCT 896 
                                  ************************************************** 
 
EORD                              CCACGCGGTGTGAAGATCACACGGGAAGGTGTGTGGCACTGAGCACAGCC 949 
chr15_52904890-52907293           CCACGCGGTGTGAAGATCACACGGCAAGGTGTGTGGCACTGAGCACAGCC 950 
chrUn_AAEX03022082_1656-4051      CCACGCGGTGTGAAGATCACACGGGAAGGTGTGTGGCACTGAGCACAGCC 946 
                                  ************************ ************************* 
 
EORD                              TCCTAATGGTGCCGACGTGTTGATGGGGGGTGGGGACCTCCTGGAGGGCT 999 
chr15_52904890-52907293           TCCTAATGGTGCCGACGTGTTGATGGGGGGTGGGGACCTCCGGGAGGGCT 1000 
chrUn_AAEX03022082_1656-4051      TCCTAATGGTGCCGACGTGTTGATGGGGGGTGGGGACCTCCGGGAGGGCT 996 
                                  ***************************************** ******** 
 
EORD                              GCTCCACGCAGCACCATGCATGTGGGAAGTAGCCTTCTTTCCAAGTCCAT 1049 
chr15_52904890-52907293           GCTCCACGCAGCACCATGCATGTGGGAAGTAGCCTTCTTTCCAAGTCCAT 1050 
chrUn_AAEX03022082_1656-4051      GCTCCACGCAGCACCATGCATGTGGGAAGTAGCCTTCTTTCCAAGTCCAT 1046 
                                  ************************************************** 
 
EORD                              TGTAGTGTCGGACAGCACAGGAAAGGCACTTTAGTTAGAAGATGGGAGGG 1099 
chr15_52904890-52907293           TGTAGTGTCGGACAGCACAGGAAAGGCACTTTAGTTAGAAGATGGGAGGG 1100 
chrUn_AAEX03022082_1656-4051      TGTAGTGTCGGACAGCACAGGAAAGGCACTTTAGTTAGAAGATGGGAGGG 1096 
                                  ************************************************** 
 
EORD                              AACTAAGCAGGTTGCAGGCCACCAGGCCTACATGGAGACTGAAGTCGGGT 1149 
chr15_52904890-52907293           AACTAAGCAGGTTGCAGGCCACCAGGCCTACATGGAGACTGAAGTCGGGT 1150 
chrUn_AAEX03022082_1656-4051      AACTAAGCAGGTTGCAGGCCACCAGGCCTACATGGAGACTGAAGTCGGGT 1146 
                                  ************************************************** 
 
EORD                              CAAGAGCTCACATAAGAGCTGGTCTTAAAGACACATATAAAATTCAAGAT 1199 
chr15_52904890-52907293           CAAGAGCTCACATAAGAGCTGGTCTTAAAGACACATATAAAATTCAAGAT 1200 
chrUn_AAEX03022082_1656-4051      CAAGAGCTCACATAAGAGCTGGTCTTAAAGACACATATAAAATTCAAGAT 1196 
                                  ************************************************** 
 
EORD                              GGAAAAGAGGAAAACTGGAGGTGGATGTCTGATGACCCTTCCCATTCTTG 1249 
chr15_52904890-52907293           GGAAAAGAGGAAAACCGGAGGTGGATGTCTGATGACCCTTCCCATTCTTG 1250 
chrUn_AAEX03022082_1656-4051      GGAAAAGAGGAAAACCGGAGGTGGATGTCTGATGACCCTTCCCATTCTTG 1246 
                                  *************** ********************************** 
 
EORD                              GCTAAGT----CATAAGACTGAAGTCAGTTTTTAATAGTGAAAAGTGAAG 1295 
chr15_52904890-52907293           GCTAAGTAAGTCATAAGACTGAAGTCAGTTTTTAATAGTGAAAAGTGAAG 1300 
chrUn_AAEX03022082_1656-4051      GCTAAGTAAGTCATAAGACTGAAGTCAGTTTTTAATAGTGAAAAGTGAAG 1296 
                                  *******    *************************************** 
 
EORD                              TAAGAGTTAATAGGTGGTCAGAAGCAATCACATGTTCCTAATCAGTAGTG 1345 
chr15_52904890-52907293           TAAGAGTTAATAGGTGGTCAGAAGCAATCACATGTTCCTAATCAGTAGTG 1350 
chrUn_AAEX03022082_1656-4051      TAAGAGTTAATAGGTGGTCAGAAGCAATCACATGTTCCTAATCAGTAGTG 1346 
                                  ************************************************** 
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EORD                              TCAGATCTATTCCACAACAACAAAATAGAAATCTCTGTGTATCTGTTTCC 1395 
chr15_52904890-52907293           TCAGATCTATTCCACAACAACAAAATAGAAATCTCTGTGTATCTGTTTCC 1400 
chrUn_AAEX03022082_1656-4051      TCAGATCTATTCCACAACAACAAAATAGAAATCTCTGTGTATCTGTTTCC 1396 
                                  ************************************************** 
 
EORD                              TTGCGAGAGGATTATATTTATGTCAAACTGAAATGTATGGAGTACCAGAA 1445 
chr15_52904890-52907293           TTGCGAGAGGATTATATTTATGTCAAACTGAAATGTATGGAGTACCAGAA 1450 
chrUn_AAEX03022082_1656-4051      TTGCGAGAGGATTATATTTATGTCAAACTGAAATGTATGGAGTACCAGAA 1446 
                                  ************************************************** 
 
EORD                              AGGAAATCAGAAATCCATTCTTTTATATACAGGTTATTTTGCCATTTAAA 1495 
chr15_52904890-52907293           AGGAAATCAGAAATCCATTCTTTTATATACAGGTTATTTTGCCATTTAAA 1500 
chrUn_AAEX03022082_1656-4051      AGGAAATCAGAAATCCATTCTTTTATATACATGTTATTTTGCCATTTAAA 1496 
                                  ******************************* ****************** 
 
EORD                              AACCAGTGGCTTTAGAAATGTTACTGAGAGATATTTTACTGACTTAAAAA 1545 
chr15_52904890-52907293           AACCAGTGGCTTTAGAAATGTTACTGAGAGATATTTTACTGACTTAAAAA 1550 
chrUn_AAEX03022082_1656-4051      AACCAGTGGCTCTAGAAATGTTACTGAGAGATATTTTACTGACTTAAAAA 1546 
                                  *********** ************************************** 
 
EORD                              TCCAGAATAACTTCCACTTCTATATGTCAGATTACCTGTTCATTTTGGAT 1595 
chr15_52904890-52907293           TCCAGAATAACTTCCACTTCTATATGTCAGATTACCTGTTCATTTTGGAT 1600 
chrUn_AAEX03022082_1656-4051      TCCAGAATAACTTCCACTTCTATATGTCAGATTACCTGTTCATTTTGGAT 1596 
                                  ************************************************** 
 
EORD                              CCTTAAGTTCTCACTTTCAATCCTTTTAATTCTGTGCATTTCATGTAAAT 1645 
chr15_52904890-52907293           CCTTAAGTTCTCACTTTCAATCCTTTTAATTCTGTGCATTTCATGTAAAT 1650 
chrUn_AAEX03022082_1656-4051      CCTTAAGTTCTCACTTTCAATCCTTTTAATTCTGTGCATTTCATGTAAAT 1646 
                                  ************************************************** 
 
EORD                              ACACATTTTTCTTTTCTAACCACTCCTGAGAAAATAAGAAAAAAAGAATA 1695 
chr15_52904890-52907293           ACACATTTTTCTTTTCTAACCACTCCTGAGAAAATAAGAAAAAAAGAATA 1700 
chrUn_AAEX03022082_1656-4051      ACACATTTTTCTTTTCTAACCACTCCTGAGAAAATAAGAAAAAAAGTATA 1696 
                                  ********************************************** *** 
 
EORD                              GAATGTTCAGTTTCCCAAAAGAATTAGAATTCTTATCCATTTCTGAAATA 1745 
chr15_52904890-52907293           GAATGTTCAGTTTCCCAAAAGAATTAGAATTCTTATCCATTTCTGAAATA 1750 
chrUn_AAEX03022082_1656-4051      GAATGTTCAGTTTCCCAAAAGAATTAGAATTCTCATCCATTTCTGAAATA 1746 
                                  ********************************* **************** 
 
EORD                              CTATAAATTTTTAAAACGGCAAACAAAATTTAGAAATTCCATATAAGCCA 1795 
chr15_52904890-52907293           CTATAAATTTTTAAAACGGCAAACAAAATTTAGAAATTCCATATAAGCCA 1800 
chrUn_AAEX03022082_1656-4051      CTATAAATTTTTAAAACGGCAAACAAAATTTAGAAATTCCATATAAGCCA 1796 
                                  ************************************************** 
 
EORD                              GTATCATGCTTCTTTTTTCTGATAATATTCTAATACGTAAAGACGAGCAT 1845 
chr15_52904890-52907293           GTATCATGCTTCTTTTTTCTGATAATATTCTAATACGTAAAGACGAGCAT 1850 
chrUn_AAEX03022082_1656-4051      GTATCATGCTTCTTTTTTCTGATAATATTCTAATACGTAAAGACGAGCAT 1846 
                                  ************************************************** 
 
EORD                              GAGTTAAGAAAAATACGTTATCTTTCTTAGTTTTAACAACAGACTTCAAA 1895 
chr15_52904890-52907293           GAGTTAAGAAAAATACGTTATCTTTCTTAGTTTTAACAACAGACTTCAAA 1900 
chrUn_AAEX03022082_1656-4051      GAGTTAAGAAAAATACGTTATCTTTCTTAGTTTTAACAACAGACTTCAAA 1896 
                                  ************************************************** 
 
EORD                              GATTGAATATAATGGCTACATAAGTTAACATTTTTTTCTCCAAAATTTTT 1945 
chr15_52904890-52907293           GATTGAATATAATGGCTACATAAGTTAACATTTTTTTCTCCAAAATTTTT 1950 
chrUn_AAEX03022082_1656-4051      GATTGAATATAATGGCTACATAAGTTAACATTTTTTTCTCCAAAATTTTT 1946 
                                  ************************************************** 
 
EORD                              AAGTACAATTTTCTAAAGTGTACTGTTTTGTATAACAAACAAGACCAAAA 1995 
chr15_52904890-52907293           AAGTACAATTTTCTAAAGTGTACTGTTTTGTATAACAAACAAGACCAAAA 2000 
chrUn_AAEX03022082_1656-4051      AAGTACAATTTTCTAAAGTGTACTGTTTTGTATAACAAACAAGACCAAAA 1996 
                                  ************************************************** 
 
EORD                              AAAGAACCTCTTTTGGAATTGTGAAGACAAATCAAGAAAGTCTTTTTCTC 2045 
chr15_52904890-52907293           AAAGAACCTCTTTTGGAATTGTGAAGACAAATCAAGAAAGTCTTTTTCTC 2050 
chrUn_AAEX03022082_1656-4051      AAAGAACCTCTTTTGGAATTGTGAAGACAAATCAAGAAAGTCTTTTTCTC 2046 
                                  ************************************************** 
 
EORD                              TGTAAGCTTAATGAAATTACAAGGCCCAAGAAAAAATTAAAACTCTTTTA 2095 
chr15_52904890-52907293           TGTAAGCTTAATGAAATTACAAGGCCCAAGAAAAAATTAAAACTCTTTTT 2100 
chrUn_AAEX03022082_1656-4051      TGTAAGCTTAATGAAATTACAAGGCCCAAGAAAAAATTAAAACTCTTTTA 2096 
                                  *************************************************  
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EORD                              GTTCTTAACAATATACATGTTAAGAAGAAAAAGAATATAAACATATATAG 2145 
chr15_52904890-52907293           GTTCTTAACAATATACATTTTAAGAAGAAAAAGTATAAAAACATATATAG 2150 
chrUn_AAEX03022082_1656-4051      GTTCTTAACAATATACATGTTAAGAAGAAAAAGAATATAAACATATATAG 2146 
                                  ****************** ************** *** ************ 
 
EORD                              ACATTAACCACATTTTTGCTTCTACTGTATTTTTATAAAGTGCTGTGGCA 2195 
chr15_52904890-52907293           ACATTAACCACATTT--GCTTCTACTGTATTTTTATAAAGTGCTGTGGCA 2198 
chrUn_AAEX03022082_1656-4051      ACATTAACCACATTTTTGCTTCTACTGTATTTTTATAAAGTGCTGTGGCA 2196 
                                  ***************  ********************************* 
 
EORD                              TATTCTCTTAAACAACTATGATCAGTTAAGCAAAGCTTGGAAGGAAATAA 2245 
chr15_52904890-52907293           TATTCTCTTAAACAACTATGATCAGTTAAGCAAAACTTGGAAGGAAATAA 2248 
chrUn_AAEX03022082_1656-4051      TATTCTCTTAAACAACTATGATCAGTTAAGCAAAGCTTGGAAGGAAATAA 2246 
                                  ********************************** *************** 
 
EORD                              TTTAGTAAAAATACCTCTGGGTTGTTCAGATATTATAAAGGAAAAT--TT 2293 
chr15_52904890-52907293           TTTAGTAAAAATAACTCTGGGTTGCTCAGATATTATAAAGGAAAATGTTT 2298 
chrUn_AAEX03022082_1656-4051      TTTAGTAAAAATACCTCTGGGTTGTTCAGATATTATAAAGGAAAAT--TT 2294 
                                  ************* ********** *********************  ** 
 
EORD                              TTTTTTTTAAGATTTTATTTATT----CATGAGAGACACACAGAGAGGCA 2339 
chr15_52904890-52907293           TTTTTTTTAAGATTTTATTTATTTATTCATGAGAGACACACAGAGAGGCA 2348 
chrUn_AAEX03022082_1656-4051      TTTTTTTTAAGATTTTATTTATT----CATGAGAGACACACAGAGAGGCA 2340 
                                  ***********************    *********************** 
 
EORD                              TAGACACAGGCAGAGGGAGAATCAGGCTCCCTGTGGGGAGCCCGATGTGG 2389 
chr15_52904890-52907293           TAGACACAGGCAGAGGGAGAATCAGGCTCCCTGTGGGGAGCCCAATGTGG 2398 
chrUn_AAEX03022082_1656-4051      TAGACACAGGCAGAGGGAGAATCAGGCTCCCTGTGGGGAGCCCGATGTGG 2390 
                                  ******************************************* ****** 
 
EORD                              GACTCG 2395 
chr15_52904890-52907293           GACTCG 2404 
chrUn_AAEX03022082_1656-4051      GACTCG 2396 
                                  ****** 
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Supplementary File 4 
MAP9 
Residue 
Number 
Amino 
acid 
loPRA 
Amino 
acid 
eoPRA 
Amino 
acid 
Human 
(hg19) 
PolyPhen 
prediction 
Prodominantly 
conserved 
residue 
Number of 
vertebrate 
species in 
comparison 
 vertebrate 
conservation 
(%) 
Notes 
203 R/C* C S Probably 
damaging 
S 63 41 Naturally occuring canine 
polymorphism 
334 I/K* K K Benign K 57 60 Naturally occuring canine 
polymorphism 
489 Q R K Benign K 75 80 eoPRA residue in Pika, cape 
elephant shrew 
490 R K K Benign K 75 96 eoPRA residue is the same as 
the conserved residue 
517 R Q K Possibly 
damaging 
K 70 69  
555 N K N Probably 
damaging 
N 70 84  
576 E V E Benign E 72 85 eoPRA residue in Tibetan 
antelope, cow, sheep, domestic 
goat, manatee. 
579 N S N Probably 
damaging 
N 71 73 eoPRA residue in big brown bat 
584 E - E  E 71 92 Residue also absent in chicken 
 
CLUSTAL O(1.2.1) Multiple sequence alignment for MAP9 
 
                      Exon  2                    Exon 3 
Human        MSDEVFSTTLAYTKSPKVTKRTTFQDELIRAITARSARQRSSEYSDDFDSDEIVSLGDFS 
LoPRA        MSDEVFSTILAYTKSPKVTKRTTFQDELIKAITARSARQRSSEYSDDFDSDEIVSLGDFS 
EoPRA        MSDEVFSTILAYTKSPKVTKRTTFQDELIKAITARSARQRSSEYSDDFDSDEIVSLGDFS 
             ******** ********************:****************************** 
                                        Exon 4 
Human        DTSADENSVNKKMNDFHISDDEEKNPSKLLFLKTNKSNGNITKDEPVCAIKNEEEMAPDG 
LoPRA        DTSVDENSNKKKMNDFHISDDEEKNSPKLSFLKTKKSNSDIMKDEPVFSTKNDEEMAPDG 
EoPRA        DTSVDENSNKKKMNDFHISDDEEKNSPKLSFLKTKKSNSDIMKDEPVFSTKNDEEMAPDG 
             ***.**** :***************  ** ****:***.:* ***** : **:******* 
                                                              Exon 5 
Human        CEDIVVKSFSESQNKDEEFEKDKIKMKPKPRILSIKSTSSAENNSLDTDDHFKPSPRPRS 
LoPRA        CGNMVGTPLSESQNNDQEIEKDKIKMKPKPRILPVKSMSSENNSSPEANNHFKPSPRPRS 
EoPRA        CGNMVGTPLSESQNNDQEIEKDKIKMKPKPRILPVKSMSSENNSSPEANNHFKPSPRPRS 
             * ::* . :*****:*:*:************** :** ** :*.* ::::********** 
                            
Human        MLKKKSHMEEKDGLED-KETALSEELELHSAPSSLPTPNGIQLEAEKKAFSENLDPEDSC 
LoPRA        MLKKHSHGEEKDGPGEGKTPALREELEARSAPSPLPKLNDGQLEAEKKLASENLDPKDPW 
EoPRA        MLKKHSHGEEKDGPGEGKTPALCEELEARSAPSPLPKLNDGQLEAEKKLASENLDPKDPW 
             ****:** *****  : *  ** **** :**** **. *  *******  ******:*   
                       Exon 6                            Exon 7 
Human        LTSLASSSLKQILGDSFSPGSEGNASGKDPNEEITENHNSLKSDENKENSFSADHVTTAV 
LoPRA        LTSLSSSSLKENLGDSFSPGSGGKASVEDQNEELTENHNSLKSNENEGNSFLIDLVTTPI 
EoPRA        LTSLSSSSLKENLGDSFSPGSGGKASVEDQNEELTENHNSLKSNENEGNSFLIDLVTTPI 
             ****:*****: ********* *:** :* ***:*********:**: ***  * *** : 
                                        
Human        EKSKESQVTADDLEEEKAKAELIMDDDRTVDPLLSKSQSILISTSATASSKKTIEDRNIK 
LoPRA        EKSQESQVITDDLEEEKEKAELIMNDL-TVDPLF-ISQSILISADTTESSKKTVEDRNMK 
EoPRA        EKSQESQVITDDLEEEKEKAELIMNDL-TVDPLF-KSQSILISADTTESSKKTVEDRNMK 
             ***:**** :******* ******:*  *****:  *******:.:* *****:****:* 
                 Exon 8                          Exon 9 
Human        NKKSTNNRASSASARLMTSEFLKKSSSKRRTPSTTTSSHYLGTLKVLDQKPSQKQSIEPD 
LoPRA        NKKSTNNRASSASGRLMTSEFLKKSSSIRRPPSTTTSSHYLGTLKVLDQKPSQKQNIEPE 
EoPRA        NKKSTNNRASSASGRLMTSEFLKKSSSIRRPPSTTTSSHYLGTLKVLDQKPSQKQNIEPE 
             *************.************* ** ************************.***: 
                                  Exon 10                     Exon 11 
Human        RADNIRAAVYQEWLEKKNVYLHEMHRIKRIESENLRIQNEQKKAAKREEALASFEAWKAM 
LoPRA        KADSIRAAVYQEWLEKKNVYLHEMHRIKRIESENLRIQNEQKRAAKREEALASFEAWKAM 
EoPRA        KADSIRAAVYQEWLEKKNVYLHEMHRIKRIESENLRIQNEQKRAAKREEALASFEAWKAM 
             :**.**************************************:***************** 
                                                           Exon 12 
Human        KEKEAKKIAAKKRLEEKNKKKTEEENAARKGEALQAFEKWKEKKMEYLKEKNRKEREYER 
LoPRA        KEKEAKKIAAQRRLEEKNKKKTEEENAARKGEALQAFERWKEKKMEYLREKNKKEREYER 
EoPRA        KEKEAKKIAARKRLEEKNKKKTEEENAARKGEALQAFEQWKEKKMEYLREKNKKEREYER 
             **********::**************************:*********:***:*******  
                                                     Exon 13 
Human        AKKQKEEETVAEKKKDNLTAVEKWNEKKEAFFKQKEKEKINEKRKEELKRAEKKDKDKQA 
LoPRA        AKKQKEEETIAEKRKDNLTAIEKWNERKDAFFKEKEKEKINEKRREELKRAEKKDKDKQA 
EoPRA        AKKQKEEETIAEKRKDKLTAIEKWNERKDAFFKEKEKVKISEKRRE-LKRAEKKDKDKQA 
             *********:***:**:***:*****:*:****:*** **.***: ************** 
                                     Exon 14 
Human        INEYEKWLENKEKQERIERKQKKRHSFLESEALPPWSPPSRTVFAKVF 
LoPRA        IDEYEKWLEKKERQERIERKQKKRHSFLENEALPPWSPPSRTVFSRVF 
EoPRA        IDEYEKWLEKKERQERIERKQKKRHSFLENEALPPWSPPSRTVFSRVF 
             *:*******:**:****************.**************::** 
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Supplementary File 5
MAP9  deletion genotyping results
Breed ID Category of onset Age of diagnosis
Top SNP 
Genotype
MAP9  Genotype
MLHD 7921 E 0.3 G/G wt/wt Key
MLHD 7912 E 0.5 T/T N/A E Early onset PRA
MLHD MLD27 E 1.0 T/T N/A L Late onset PRA
MLHD MLD37 E 1.0 T/T del/del MLHD Miniature Long Haired Dachshund
MLHD MLD28 E 1.5 T/T del/del MWHD Miniature Wire Haired Dachshund
MLHD MLD29 E 1.3 T/T del/del CCR  Curly Coat Retriever
MLHD MLD30 E 1.8 T/T del/del ESS English Springer Spaniel
MLHD MLD31 E 1.8 T/T del/del
MLHD 7916 E 1.8 T/T del/del
MLHD 7920 E 1.8 T/T del/del
MLHD 5898 E 1.9 T/T del/del
MLHD MLD34 E <2.0 T/T del/del
MLHD MLD66 E 2.0 T/T del/del
MLHD 6088 E 2.2 T/T del/del
MLHD 17795 E 2.6 G/G wt/wt
MLHD MLD2 E 2.7 T/T del/del
MLHD MLD32 E 3.0 T/T del/del
MLHD MLD70 E 3.0 T/T del/del
MLHD 7918 E 3.0 T/G wt/del
MLHD MLD64 E <3.4 T/T del/del
MLHD MLD25 E 4.0 T/T del/del
MLHD 7910 E 4.0 T/T del/del
MLHD MLD4 E 2.4-5.2 T/T del/del
MLHD MLD21 E 5.0 T/T del/del
MLHD MLD23 E 5.0 T/T del/del
MLHD MLD9 L 5.2-6.6 T/T del/del
MLHD MLD291 L 5.6 G/G wt/wt
MLHD MLD10 L Normal @ 6.1 T/G wt/del
MLHD 11044 L 6.3 G/G wt/wt
MLHD MLD39 L 7.0 T/G wt/wt
MLHD 11056 L 7.7 T/G wt/wt
MLHD MLD3 L 7.8-9.3 T/G wt/del
MLHD MLD61 L 8.0 T/G wt/del
MLHD MLD65 L SARD @ 8.0 T/G wt/del
MLHD MLD132 L Normal @ 8.5 T/G wt/del
MLHD 11057 L 8.8 T/G wt/wt
MLHD MLD6 L Normal @ 8.9 G/G wt/wt
MLHD MLD24 L 9.0 T/G wt/wt
MLHD MLD1 L 9.2-10.6 T/G wt/del
MLHD MLD7 L 9.4 T/G wt/del
MLHD MLD5 L >10.8 T/T wt/del
MLHD MLD153 L Normal @ 10.8 G/G wt/wt
MWHD 11063 L 5.4 G/G wt/wt
MWHD 11058 L 6.4 G/G wt/wt
MWHD 11062 L 7.7 T/G wt/del
CCR 22329 E 2.0 G/G wt/wt
ESS 6860 E (GPRA) 2.7 T/G wt/wt
ESS 6862 E (GPRA) 2.7 T/G wt/wt
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MLHD EORD 
read 
alignments 
Tibetan 
Terrier read 
alignments 
Brittany 
Spaniel read 
alignments 
chr15 
Position (bp) 
in CanFam3.1 
MAP9_CORRECTED 
52,905,000 52,915,000 52,925,000 
28 kb 
MAP9pseudogene MAP9 
Gene 
annotation 
Supplementary File 6 
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